Moderna, on the heels of pharma rivals, cleared to advance RSV vaccine
Dive Brief:
Moderna is set to begin late-stage testing of a vaccine to prevent a common respiratory infection, announcing Tuesday that independent data monitors de...
Continue Reading →
